WARD Rehab
WARD-Rehab: Validation Study of Monitoring Rehabilitation Patients with WARD Equipment
Study design:
Observational
Sample size:
20 participants
Study Sites
Center for Rehabilitation and Acute Care – Bystævneparken (Formerly Dortheagården)
Inclusion criteria
Adult patients that are transfferred from the hospital ward to a temporary day stay (Midlertidigt Døgnophold – MDO) with WARD monitoring equipment.
Study Procedures
Included patients were monitored with WARD equipment during their temporary day stay.
Primary outcome
Primary outcome is the amount and duration of physiological parameter deviations.
Primary Investigators
Jesper Mølgaard, MD, PhD student
NCT link
None
WARD COVID-19
WARD COVID-19
Study design:
Observational study
Sample size:
Up to 300 participants
Study Sites
Rigshospitalet, Bispebjerg Hospital, Hvidovre Hospital, Nordsjællands Hospital (Hillerød), Sjællands University Hosptial (Køge), Odense University Hospital, Aalborg University Hospital.
Inclusion criteria
Adult patients (from 18 years of age) admitted with a confirmed COVID-19 infection, where study inclusion is possible within 72 hours of admission OR within 48 hours of discharge from ICU to a medical ward, and at least one overnight stay expected.
Study Procedures
Included patients will be monitored with WARD equipment after hospital admission and will be monitored during hospitalization. Patients vital parameters are continuously monitored and visible outside of the patients room limiting patient contact and personal protective equipment (PPE) use.
Outcome
Primary outcome is the cumulative duration of physiological parameter deviations. Secondary outcome is the frequency of micro events, measured by continuous vital sign monitoring and as measured by EWS in the control group.
Primary Investigators
Katja Kjær Grønbæk, MD, PhD student
NCT:
NCT04724681
WARD-TCM
WARD-TCM: Transcutaneous Monitoring
Accuracy of Transcutaneous Monitoring of Blood Gases in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease on Non-invasive Ventilation.
Study design:
Observational study
Sample size:
20 participants
Study Sites
Rigshospitalet and Bispebjerg Hospital
Inclusion criteria
Adult patients (from 18 years of age) admitted with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) for treatment with non-invasive ventilation or mechanical ventilation.
Study Procedures
Included patients were monitored after admission to a respiratory intermediate care unit or intensive care unit during ongoing non-invasive ventilation or immediately following extubation. Levels of carbon dioxide and oxygen were monitored using both continuous transcutaneous measurement (TcPCO2 and TcPO2) and simultaneous routine arterial blood gases (PaCO2 and PaO2) for reference.
Primary outcome
Agreement between transcutaneous monitoring and arterial blood gases calculated as mean bias with 95% limits of agreement for both single point estimates of tcPCO2 vs PaCO2 and tcPO2 vs PaO2, and changes in transcutaneous gases between two timepoints (ΔtcPCO2 and ΔtcPO2).
Primary Investigators
Kasper Mørk Sørensen, Medical student
Rebecca Vienberg, MD
NCT link
None
WARD Arrythmia
WARD Arrhythmia: Exploring the detection rate of arrhythmias between single-lead ECG and Holter monitoring
Study design
Sample size
>10 participants for every arrhythmia
Study sites
Bispebjerg Hospital and Rigshospitalet
Inclusion criteria
Adult (>18 years) with known cardiac disease.
Patients admitted at Bispebjerg Hospital for elective DC cardioversion because of atrial fibrillation.
Patients admitted at Rigshospitalet for adenosine stress test.
Patients admitted at Rigshospitalet with acute myocardial infarction.
Study procedures
Included patients are simultaneously manually monitored with single-lead ECG part of WARD equipment and Holter monitoring.
Primary outome
Number of occurrences of arrhythmias that can be detected on single-lead ECG compared to Holter monitoring.
Primary Investigator
Luna Ekenberg, Medical Student
Johan Jokinen, Medical Student
Jesper Mølgaard, MD, PhD Student
NCT
None
WARD VASC
WARD-VASC: Observational Study in Patients Undergoing Major Vascular Surgery
Study design
Sample size
40 participants
Study sites
Rigshospitalet
Inclusion criteria
Adult (>18 years) patients undergoing major vascular surgery.
Study procedures
Included patients are monitored with WARD equipment from after surgery in the post anesthesia care unit (PACU) and up to 4 days postoperatively, while hospitalized.
Primary outome
Primary outcome is the amount and duration of physiological parameter deviations. Secondary outcome is the number of postoperative complications wihtin 30 days after surgery.
Primary Investigator
Jesper Mølgaard, PhD student
NCT
None